JPS51136665A - Production of nnhetercyclic derivatives of 1*44methnoo and 1*44ethanoo1*44dihydro and 1*2*3*44tetrahydroonaphthyloxy aliphatic alcohol and antii arrhythmia agent containing the same - Google Patents

Production of nnhetercyclic derivatives of 1*44methnoo and 1*44ethanoo1*44dihydro and 1*2*3*44tetrahydroonaphthyloxy aliphatic alcohol and antii arrhythmia agent containing the same

Info

Publication number
JPS51136665A
JPS51136665A JP51051260A JP5126076A JPS51136665A JP S51136665 A JPS51136665 A JP S51136665A JP 51051260 A JP51051260 A JP 51051260A JP 5126076 A JP5126076 A JP 5126076A JP S51136665 A JPS51136665 A JP S51136665A
Authority
JP
Japan
Prior art keywords
nnhetercyclic
44methnoo
44ethanoo1
44dihydro
antii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51051260A
Other languages
English (en)
Inventor
Meroni Piero
Roogeman Biirii
Rauria Furanchiesuko
Tsuruba Karura
Berugamasuki Mario
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of JPS51136665A publication Critical patent/JPS51136665A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/72—Ethanonaphthalenes; Hydrogenated ethanonaphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP51051260A 1975-05-05 1976-05-04 Production of nnhetercyclic derivatives of 1*44methnoo and 1*44ethanoo1*44dihydro and 1*2*3*44tetrahydroonaphthyloxy aliphatic alcohol and antii arrhythmia agent containing the same Pending JPS51136665A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2297675 1975-05-05

Publications (1)

Publication Number Publication Date
JPS51136665A true JPS51136665A (en) 1976-11-26

Family

ID=11202497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51051260A Pending JPS51136665A (en) 1975-05-05 1976-05-04 Production of nnhetercyclic derivatives of 1*44methnoo and 1*44ethanoo1*44dihydro and 1*2*3*44tetrahydroonaphthyloxy aliphatic alcohol and antii arrhythmia agent containing the same

Country Status (12)

Country Link
JP (1) JPS51136665A (ja)
AU (1) AU1346776A (ja)
BE (1) BE841478A (ja)
DE (1) DE2618979A1 (ja)
DK (1) DK199276A (ja)
FI (1) FI761174A (ja)
FR (1) FR2310129A1 (ja)
IL (1) IL49505A0 (ja)
NL (1) NL7604812A (ja)
NO (1) NO761525L (ja)
SE (1) SE7605071L (ja)
ZA (1) ZA762697B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516982A (ja) * 2003-02-07 2006-07-13 メルクル・ゲーエムベーハー ホスホリパーゼａ２阻害剤としての新規ヘテロアリール置換アセトン誘導体

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542623B2 (en) * 1980-05-16 1985-02-28 Bayer Aktiengesellschaft 1-hydroxyethyl-azole derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516982A (ja) * 2003-02-07 2006-07-13 メルクル・ゲーエムベーハー ホスホリパーゼａ２阻害剤としての新規ヘテロアリール置換アセトン誘導体

Also Published As

Publication number Publication date
FR2310129A1 (fr) 1976-12-03
AU1346776A (en) 1977-11-03
FI761174A (ja) 1976-11-06
DE2618979A1 (de) 1976-11-25
ZA762697B (en) 1977-04-27
SE7605071L (sv) 1976-11-06
NL7604812A (nl) 1976-11-09
NO761525L (ja) 1976-11-08
IL49505A0 (en) 1976-06-30
BE841478A (fr) 1976-09-01
DK199276A (da) 1976-11-06

Similar Documents

Publication Publication Date Title
JPS5231063A (en) Production of novel 17 betaaester of nandrolone and novel pharmaceutical agent containing same with assimirating action
HU175439B (hu) Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta
JPS5251367A (en) Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same
JPS5271485A (en) 3*44dihydrooquinazoline derivatives and their production and composition having antiiallergy effect containing same
GR63213B (en) 4-trifluormethylbenzoic acid derivatives and process of making the same and pharmaceutical compositions containing thereof
JPS52105168A (en) Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent
JPS5331670A (en) Production of aminoalkylideneaminoo 1*44dihydropyridine and use of same as medicine
JPS5268177A (en) Production of indazole derivatives and pharmaceutical composition containing the same
JPS5236666A (en) Production novel pyrazole derivatives and antii inflammatory agent containing the same
ZA75179B (en) New arylpiperazine derivatives of adenine and the preparation thereof
JPS52156869A (en) Production of benzomorphane derivatives and medical composition containing same
JPS5337669A (en) Production and use of 1*44dihydropyridine derivatives
JPS5289683A (en) Quinoxalineediinnoxide derivative * its production and antiimicrobial composition containing same
JPS5359654A (en) Novel derivatives of 99 chlorpredonisolone * production of same and pharmaceutical agent containing the same with strong antiiinflammatory acti1on
JPS51136665A (en) Production of nnhetercyclic derivatives of 1*44methnoo and 1*44ethanoo1*44dihydro and 1*2*3*44tetrahydroonaphthyloxy aliphatic alcohol and antii arrhythmia agent containing the same
JPS523051A (en) Production of fusidic acid derivatives and pharmaceutical agent containing the same
JPS5271467A (en) Production of pyrazolone derivatives and use of the same as pharmaceutical agent
JPS525759A (en) Production of acetylsalycylic acid derivatives and antiipyretic * lenitive and antiiinflammatory agent containing the same
JPS5359694A (en) Production of sstriazoloo *1*55a**pyridinee22yll5*77 dimethyllphosphoric acid derivative and harmful organism combaiting agent containing same
NZ185318A (en) Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions
JPS52253A (en) Production of 22chlorr 6 betaafluorr1*44 pregnadienee3*200dione derivatives and antii inflamatory agent containing same
JPS5214761A (en) Production of 9 alphaa fluorrsteroid and pharmaceutical composition containing the same
JPS5210298A (en) 11oxoo1hh66substituted pyrimid *1*22alpha* quinolinee 22carboxylic acid and ester thereof useful as antii tumor agent
GB1544895A (en) 17-spirosultine derivatives and the corresponding ypsilon-hydroxy acids of estr-3-ones processes for preparing them and pharmaceutical compositions containing them
JPS5315361A (en) Production of novel corticoide and pharmaceutical agent containing same with excellent antiiinflamatory action*